| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.01 |